Ectopic N‐cadherin expression in a non‐metastatic prostate cancer model induces metastatic behavior in these cells, while blocking antibodies to N‐cadherin reduced tumor growth, invasion, and metastasis, thus demonstrating the clinical relevance of N‐cadherin interactions (Tanaka et al, 2010). This evidence concerns the gene CDH2 and prostate cancer.